Nonprofit · EIN 31-1667995
CONQUER CANCER FDN OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY
Tax-exempt · ALEXANDRIA, VA 22314
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $41,435,619 | $34,781,420 | $6,654,199 | $120,676,056 | $12,476,623 | $108,199,433 |
| December 31, 2023 | 990 | $39,096,707 | $33,575,680 | $5,521,027 | $110,051,603 | $13,025,732 | $97,025,871 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $37,343,075
- Membership dues
- $1,378,500
- Program service revenue
- $364,257
- Investment income
- $3,994,373
- Net gain from sales of assets
- $881,523
- Net income from fundraising events
- -$266,086
- Other revenue
- -$266,086
Expenses
- Grants and similar amounts paid
- $18,795,488
- Salaries, compensation and benefits (total)
- $0
- Professional fundraising fees
- $301,139
- Legal fees
- $178
- Accounting fees
- $63,524
- Occupancy
- $201,928
- Travel
- $232,062
- Program services (functional)
- $23,236,784
- Management and general (functional)
- $1,640,533
- Fundraising (functional)
- $9,904,103
Balance sheet and other
- Total assets, start of year
- $110,051,603
- Total assets, end of year
- $120,676,056
- Total liabilities, end of year
- $12,476,623
- Net assets, end of year
- $108,199,433
- Publicly traded securities
- $100,096,432
- Net assets without donor restrictions
- $39,431,103
- Net assets with donor restrictions
- $68,768,330
- Gross receipts
- $44,231,076
- Employees
- 0
- Volunteers
- 300
- Year formed
- 1999
- State of legal domicile
- VA
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| CLIFFORD A HUDIS MD | EXECUTIVE VICE CHAIR Trustee or director, Officer | 6.5 | $0 | $1,114,041 | $25,875 |
| NANCY DALY MS MPH | CEO & EXECUTIVE VP Officer | 36.5 | $0 | $536,218 | $47,217 |
| MELINDA O'LEARY | CFO (PARTIAL YEAR) Officer | 1 | $0 | $259,970 | $24,887 |
| HOWARD A BURRIS III MD | BOARD CHAIR Trustee or director, Officer | 1 | $0 | $0 | $0 |
| ALEXANDER W CASDIN | TREASURER Trustee or director, Officer | 1 | $0 | $0 | $0 |
| AMY C PETERSON MD | SECRETARY Trustee or director, Officer | 1 | $0 | $0 | $0 |
| TERESA ALONSO THOMPSON | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| KATHRYN BEAL MD | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| WILLIAM BEHNKE | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| RICCARDO BRAGLIA | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| OTIS BRAWLEY MD | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| LAWRENCE H EINHORN MD | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| JASMINE FERRER MD | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| RAJ MANTENA RPH | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| THOMAS A MARSLAND MD | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
8 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| ROBERT J MAYER MD | BOARD MEMBER Trustee or director | 1 | $0 |
| GERALD J MCDOUGALL | BOARD MEMBER Trustee or director | 1 | $0 |
| ANNE MOORE MD | BOARD MEMBER Trustee or director | 1 | $0 |
| STEVEN T ROSEN MD | BOARD MEMBER Trustee or director | 1 | $0 |
| ALEXANDRA SHAPIRO | BOARD MEMBER Trustee or director | 1 | $0 |
| SANDRA SWAIN MD | BOARD MEMBER Trustee or director | 1 | $0 |
| MARGARET A TEMPERO MD | BOARD MEMBER Trustee or director | 1 | $0 |
| DEANNA B VAN GESTEL | BOARD MEMBER Trustee or director | 1 | $0 |
990 for the year ended December 31, 2023: 23 people
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| CLIFFORD A HUDIS MD | EXECUTIVE VICE CHAIR Trustee or director, Officer | 6.5 | $0 | $1,060,801 | $24,750 |
| NANCY DALY MS MPH | CEO & EXECUTIVE VP Officer | 36.5 | $0 | $516,637 | $42,677 |
| LINDA JENSEN | CFO & EXECUTIVE VP Officer | 1 | $0 | $477,532 | $42,792 |
| HOWARD A BURRIS III MD | BOARD CHAIR Trustee or director, Officer | 1 | $0 | $0 | $0 |
| AMY C PETERSON MD | SECRETARY Trustee or director, Officer | 1 | $0 | $0 | $0 |
| ALEXANDER W CASDIN | TREASURER Trustee or director, Officer | 1 | $0 | $0 | $0 |
| KATHRYN BEAL | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| WILLIAM BEHNKE | BOARD MEMBER (PARTIAL YEAR) Trustee or director | 1 | $0 | $0 | $0 |
| RICCARDO BRAGLIA | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| OTIS BRAWLEY MD | BOARD MEMBER (PARTIAL YEAR) Trustee or director | 1 | $0 | $0 | $0 |
| LAWRENCE H EINHORN MD | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| RAJ MANTENA RPH | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| THOMAS A MARSLAND MD | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| ROBERT J MAYER MD | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| GERALD J MCDOUGALL | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| ANNE MOORE MD | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| W CHARLES PENLEY MD | BOARD MEMBER (PARTIAL YEAR) Trustee or director | 1 | $0 | $0 | $0 |
| THOMAS G ROBERTS JR MD | BOARD MEMBER (PARTIAL YEAR) Trustee or director | 1 | $0 | $0 | $0 |
| STEVEN T ROSEN MD | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| ALEXANDRA SHAPIRO | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| SANDRA SWAIN MD | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| MARGARET A TEMPERO MD | BOARD MEMBER Trustee or director | 1 | $0 | $0 | $0 |
| DEANNA B VAN GESTEL | BOARD MEMBER (PARTIAL YEAR) Trustee or director | 1 | $0 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 2318 MILL RD STE 800, ALEXANDRIA, VA 22314-6834
- In care of
- % DINA L MICHELS
- Principal officer (990 for 2024)
- NANCY DALY MS MPH, 2318 MILL ROAD SUITE 800, ALEXANDRIA, VA 22314
- Signed the 990
- MELINDA O'LEARY, CFO
- Phone
- (571) 483-1700
- Website
- WWW.CONQUER.ORG
- Return prepared by
- COHNREZNICK ADVISORY LLC
Mission
CONQUER CANCER FUNDS RESEARCH FOR EVERY TYPE OF CANCER TO BENEFIT EVERY PATIENT, EVERYWHERE. WORKING IN COLLABORATION WITH A GLOBAL NETWORK OF TOP SCIENTISTS AND CLINICIANS, AND LEADING ADVOCACY AND RESEARCH ORGANIZATIONS, CONQUER CANCER DRAWS (CONTINUED IN SCHEDULE O) ON THE PASSION AND EXPERTISE OF THE CANCER PROFESSIONALS WHO ARE MEMBERS OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO). CONQUER CANCER WORKS TO HELP CREATE A WORLD WHERE CANCER IS PREVENTED OR CURED AND EVERY SURVIVOR IS HEALTHY.
Program accomplishments
- SEE SCHEDULE O:RESEARCH: RESEARCH IS HOW WE CONQUER CANCER. IT MEANS EVERYTHING, FROM UNDERSTANDING HOW CANCER IMPACTS CERTAIN PEOPLE TO FINDING GROUNDBREAKING NEW WAYS TO TREAT CANCER. THE CONQUER CANCER GRANTS & AWARDS PROGRAM HAS BEEN RECOGNIZING EXCELLENCE IN CLINICAL RESEARCH, QUALITY CARE, AND TEACHING IN THE FIELD OF ONCOLOGY SINCE 1984, WHEN THE PROGRAM ORIGINALLY BEGAN UNDER THE PURVIEW OF ASCO. CONQUER CANCER FUNDS THE ENTIRE SPECTRUM OF RESEARCH ACTIVITIES RELATED TO CANCER PREVENTION, SCREENING, TREATMENT, AND OUTCOMES RESEARCH IN ALL CANCER TYPES, AND SUPPORTS PROGRESS BY FUNDING CANCER RESEARCHERS AT ALL STAGES OF THEIR CAREERS, ENABLING ONCOLOGY'S BEST AND BRIGHTEST TO PURSUE PROMISING RESEARCH. CONQUER CANCER AND ASCO HAVE FUNDED MORE THAN $191 MILLION TO SUPPORT GRANTS & AWARDS TO OVER 9,300 RECIPIENTS IN 90 COUNTRIES. HIGHLIGHTS OF 2024 RESEARCH ACTIVITIES AND ACCOMPLISHMENTS INCLUDE: *ADVANCED CLINICAL RESEARCH AWARD (ACRA): $1,350,000 PROVIDED THREE (3) THREE-YEAR AWARDS TO PHYSICIAN-SCIENTISTS COMMITTED TO SUPPORT CLINICAL CANCER RESEARCH WITH A PATIENT-ORIENTED FOCUS. AWARDS SUPPORTED FOCUSED ON BREAST CANCER RESEARCH. *CAREER DEVELOPMENT AWARD (CDA): $4,200,000 PROVIDED TWENTY-ONE (21) THREE-YEAR AWARDS INTENDED TO SUPPORT CLINICAL RESEARCH OF CLINICAL INVESTIGATORS WHO HAVE RECEIVED THEIR INITIAL FACULTY APPOINTMENTS AND ARE ESTABLISHING INDEPENDENT CLINICAL CANCER RESEARCH PROGRAMS. *YOUNG INVESTIGATOR AWARD (YIA): $4,560,000 PROVIDED NINETY-ONE (91) ONE-YEAR AWARDS DESIGNED TO ENCOURAGE AND PROMOTE HIGH-QUALITY RESEARCH IN CLINICAL ONCOLOGY BY SUPPORTING THE RESEARCH OF PROMISING INVESTIGATORS DURING THE TRANSITION FROM A FELLOWSHIP PROGRAM TO A FACULTY APPOINTMENT. *GLOBAL ONCOLOGY YOUNG INVESTIGATOR AWARD: $300,000 PROVIDED FIVE (6) ONE-YEAR AWARDS TO EARLY-CAREER INVESTIGATORS TO SUPPORT RESEARCH IN GLOBAL ONCOLOGY AND TO DEVELOP THE NEXT GENERATION OF RESEARCHERS TO ADDRESS GLOBAL HEALTH NEEDS. THIS IS A MENTORED AWARD AND THE RESEARCH PROJECT IS CONDUCTED UNDER THE GUIDANCE OF A SCIENTIFIC MENTOR. *INTERNATIONAL INNOVATION GRANT: $39,500 PROVIDED TWO (2) ONE-YEAR AWARDS IN SUPPORT OF NOVEL AND INNOVATIVE PROJECTS THAT HAVE THE POTENTIAL TO REDUCE THE CANCER BURDEN IN LOCAL COMMUNITIES, WHILE ALSO BEING POTENTIALLY TRANSFERRABLE TO OTHER LOW- OR MIDDLE- INCOME SETTINGS. *LONG-TERM INTERNATIONAL FELLOWSHIP: $115,000 PROVIDED ONE (1) ONE YEAR GRANT WHICHENABLES AN EARLY CAREER MEMBER ONCOLOGIST IN A LOW TO MIDDLE INCOME COUNTRY AND THEIR MENTOR IN THE UNITED STATES OR CANADA TO EXTEND THE COLLABORATION THROUGH A RESEARCH FELLOWSHIP AT THE MENTOR'S INSTITUTION.THROUGH ITS EVERYGRANT PROGRAM, CONQUER CANCER UTILIZES ITS SKILLS AND EXPERTISE IN GRANTS ADMINISTRATION AND PROGRAM MANAGEMENT TO COLLABORATE WITH OTHER ORGANIZATIONS TO DEVELOP AND DELIVER PROGRAMS THAT MAKE A DIFFERENCE TO CANCER CARE TEAMS AND PATIENTS EVERYWHERE.Expenses $15,850,256 · grants $11,835,076 · revenue $364,257
- SEE SCHEDULE O:PROFESSIONAL EDUCATION: CONQUER CANCER SUPPORTS THE EFFORTS OF ASCO TO PROVIDE EDUCATION PROGRAMS IN THE US AND INTERNATIONALLY WHICH PROMOTE THE VITAL EXCHANGE OF IDEAS AND LATEST DEVELOPMENTS THAT LEAD TO WORLD-CLASS CARE, EVERYWHERE. FUNDS FROM CONQUER CANCER ARE USED TO SUPPORT ASCO'S SCIENTIFIC AND EDUCATIONAL PROGRAMS THROUGH BOTH MEETINGS AND ELECTRONIC EDUCATION OFFERINGS. HIGHLIGHTS OF THE PROFESSIONAL EDUCATIONAL AND SCIENTIFIC PROGRAMS SUPPORTED BY CONQUER CANCER AND PRESENTED TO THE PUBLIC IN 2024 INCLUDE THE FOLLOWING: * ASCO ANNUAL MEETING: THE ASCO ANNUAL MEETING IS A GLOBAL GATHERING OF MORE THAN 44,000 PARTICIPANTS WHERE ONCOLOGY PROFESSIONALS CONNECT, COLLABORATE, AND INSPIRE. THE MEETING IS KNOWN FOR ADVANCING THE ONCOLOGY FIELD AND OFFERS AN EXPERIENCE UNLIKE ANY OTHER, BRINGING TOGETHER THE BEST MINDS TO SHAPE THE FUTURE OF CANCER CARE. *GASTROINTESTINAL CANCERS (GI) SYMPOSIUM: THIS IS ONE OF THE PREMIER MULTIDISCIPLINARY GI CANCER SCIENTIFIC AND EDUCATIONAL MEETINGS. THE SYMPOSIUM OFFERS THE LATEST INNOVATIVE SCIENCE, SOLUTION-FOCUSED STRATEGIES, AND MULTIDISCIPLINARY APPROACHES IN GI CANCER TREATMENT, RESEARCH, AND CARE. *GENITOURINARY CANCERS (GU) SYMPOSIUM: THE GU SYMPOSIUM OFFERS AN UNPARALLELED MEETING EXPERIENCE THAT HELPS ATTENDEES TO REMAIN AT THE FOREFRONT OF ADVANCES IN GU CANCER CARE. AS ONE OF THE ONLY WORLD-CLASS SYMPOSIA OF ITS KIND, THE SYMPOSIUM UNVEILS PARADIGM-SHIFTING DISCOVERIES AND FOSTERS COLLABORATIONS THAT WILL TRANSFORM GU CANCER CARE.Expenses $6,121,671 · grants $5,914,045
- SEE SCHEDULE O:*QUALITY CARE SYMPOSIUM: THIS PREMIER MEETING FOCUSES ON IMPROVING THE QUALITY, SAFETY, AND EFFICIENCY OF CANCER CARE DELIVERY, BRINGING TOGETHER THE ENTIRE CLINICAL CARE TEAM TO EXPLORE THE LATEST ADVANCEMENTS IN QUALITY IMPROVEMENT THROUGH RESEARCH, EDUCATION, AND DISCUSSIONS. *MERIT AND ABSTRACT AWARDS: $294,000 PROVIDED TWO HUNDRED EIGHTY-NINE (289) MERIT AWARDS TO PROMOTE CLINICAL RESEARCH BY AWARDING YOUNG SCIENTISTS WHOSE RESEARCH IS ADDRESSED IN HIGH QUALITY ABSTRACTS SUBMITTED TO ASCO MEETINGS WITH AN OPPORTUNITY TO PRESENT THEIR RESEARCH AT ASCO SCIENTIFIC MEETINGS AND DISEASE SPECIFIC SYMPOSIA. $40,000 PROVIDED FORTY (40) ABSTRACT AWARDS TO THE PRESENTING AUTHORS OF THE 40 HIGHEST-RATED ABSTRACTS SELECTED FOR PRESENTATION AT THE ASCO BREAKTHROUGH MEETING THAT FOCUSES ON HOW INNOVATIONS IN TECHNOLOGY CREATE BOTH SOLUTIONS AND CHALLENGES IN PATIENT CARE AND RESEARCH.Expenses $1,264,857 · grants $1,046,367
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 31-1667995
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1999
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H113)
- Assets (IRS master file)
- $120,676,056
- Income (IRS master file)
- $44,231,076
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $41,435,619 | $34,781,420 | $120,676,056 | XML |
| 990 | December 2023 | $39,096,707 | $33,575,680 | $110,051,603 | XML |
| 990 | December 2022 | $33,133,692 | $32,888,928 | $98,117,170 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990-T | December 2020 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 31-1667995).
Questions about CONQUER CANCER FDN OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY
- What is the EIN of CONQUER CANCER FDN OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY?
- The employer identification number (EIN) of CONQUER CANCER FDN OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY is 31-1667995.
- Is CONQUER CANCER FDN OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1999.
- Are donations to CONQUER CANCER FDN OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does CONQUER CANCER FDN OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of CONQUER CANCER FDN OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did CONQUER CANCER FDN OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of CONQUER CANCER FDN OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY?
- The 990 for the year ended December 31, 2024 names NANCY DALY MS MPH.
- Who are the officers and directors of CONQUER CANCER FDN OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY?
- The 990 for the year ended December 31, 2024 lists 23 people; 0 received compensation from the organization.
- How much revenue does CONQUER CANCER FDN OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $41,435,619, expenses of $34,781,420 and total assets of $120,676,056 at year end.
Other nonprofits in ALEXANDRIA
- PREVENT CANCER FOUNDATION EIN 52-1429544 · last filed 990 for 2025
- HEALTHCARE REGULATORY RESEARCH INSTITUTE EIN 61-1848085 · last filed 990 for 2024
- AMGA FOUNDATION INC EIN 54-6059304 · last filed 990 for 2024
- IVI FOUNDATION INC EIN 83-2257857 · last filed 990 for 2025
- INTERNATIONAL SOCIETY FOR CEREBRAL BLOOD FLOW AND METABOLISM INC EIN 13-3418286 · last filed 990 for 2024
- FOUNDATION TO ERADICATE DUCHENNE INC EIN 71-0874241 · last filed 990 for 2025
- NEURO DEVELOPMENTAL TREATMENT ASSOCIATION INC EIN 39-1291165 · last filed 990 for 2024
- THE AOPA FOUNDATION EIN 80-0381934 · last filed 990-EZ for 2024